132 applicants
Pfizer · 2 days ago
Scientist, Conjugation Process Development
Bothell, WA
Full-time
Onsite
Senior Level
$75K/yr - $125K/yr
4+ years exp
Wonder how qualified you are to the job?
Maximize your interview chancesBiotechnologyHealth Care
Insider Connection @Pfizer
Responsibilities
With guidance from senior group members, design, execute, and interpret studies intended to answer a defined question within the defined timeframe. Design subsequent experiments upon interpretation of data.
Work with cytotoxic chemicals to prepare ADCs for toxicology studies, team supply, and investigational purposes.
Support transfer of processes to manufacturing sites.
Represent Conjugation on cross-functional teams.
Independently author technical reports and draft relevant sections of regulatory filings with aid of templates.
Prepare and present experimental results to project teams.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor's Degree and 6+ years of experience or Master's degree and 4+ years of experience
Degree in chemistry, biochemistry, chemical engineering, or related field
Direct experience with antibodies, proteins, and/or bioconjugation
Good understanding of analytical protein characterization (HPLC, IEF, CE-SDS)
Willingness to work with highly potent cytotoxic molecules while adhering to defined safety procedures
Excellent oral and written communication skills
Preferred
Experience with tangential flow filtration
Statistical software use, such as JMP
Experience with GMP manufacturing
Familiarity with CMC team function
Experience with technology transfer to manufacturing
Benefits
401(k) plan with Pfizer Matching Contributions
Pfizer Retirement Savings Contribution
Paid vacation, holiday, and personal days
Paid caregiver/parental and medical leave
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
10,001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$31B2023-05-16Post Ipo Debt· $31B
1978-01-13IPO· nyse:PFE
Leadership Team
Ian Read
CEO
Caroline Roan
Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The Pfizer
Recent News
2024-06-05
MarketScreener
2024-06-04
Company data provided by crunchbase
